Stock Events

Stock Events

Invesco Biotechnology & Genome

M$1,113.1

10

+M$0+0% Friday 18:45

Statistics

Day High

1,113.1

Day Low

1,113.1

52W High

1,425

52W Low

1,058

Volume

0

Avg. Volume

0

Mkt Cap

6.45B

P/E Ratio

3.17

Dividend Yield

0.05%

Dividend

0.55

Upcoming

Dividend Payment

Dividend Payment

Dividend Payment

Dividend Payment

Dividends

0.05%Dividend Yield

10Y Growth

-17.12%

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

127.92%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PBE.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Nasdaq Biotechnology ETF, tracks a similar biotech index, making it a direct competitor in the biotech ETF space.

SPDR S&P Biotech ETF, offers exposure to the biotechnology sector, competing directly with PBE in terms of sector focus.

VanEck Vectors Biotech ETF, focuses on biotech firms, closely competing with PBE's investment theme.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, targets the biotech industry, similar to PBE's investment strategy.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF, invests in healthcare innovation, including biotech, making it a competitor.

ARK Genomic Revolution

ARK Genomic Revolution ETF, focuses on genomic revolution, directly competing with PBE's genome investment focus.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, targets biotech and healthcare breakthroughs, competing in the same niche as PBE.

Virtus LifeSci Biotech Clinical Trials

Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech clinical trials, offering a similar investment focus to PBE.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF, specifically targets the genomics sector, making it a direct competitor to PBE's genome focus.

iShares Genomics Immunology and Healthcare

iShares Genomics Immunology and Healthcare ETF, focuses on genomics and immunology, competing with PBE's thematic investment approach.

About

The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Show more...

CEO

ISIN

US46137V7872

Listings